Director Sarah R. Davis filed a Form 4 with the SEC on November 10, 2026, disclosing two transactions in Amdocs Ltd ordinary shares dated November 9, 2026, including a purchase and an award of restricted stock units.

Key Highlights

  • Reporting person: Sarah R. Davis, identified as a Director of Amdocs Ltd (NASDAQ:DOX).
  • Purchase transaction: Davis acquired 822 ordinary shares on November 9, 2026, at a price of $42.7341 per share (transaction code P).
  • Award transaction: Davis received 6,058 ordinary shares on November 9, 2026, at a price of $0 (transaction code A).
  • Post-transaction ownership: Following the reported transactions, Davis beneficially owned 23,368 ordinary shares directly, including shares subject to outstanding restricted stock units.
  • Ownership form: All reported holdings are held directly.

Sarah Davis Reports Two Ordinary Share Transactions on November 9, 2026

According to the Form 4 filed on November 10, 2026, Amdocs Ltd director Sarah R. Davis reported two transactions in the company's ordinary shares, both dated November 9, 2026. The first transaction, coded "P," reflects a purchase of 822 ordinary shares at $42.7341 per share. Following that transaction, the filing indicates Davis held 17,310 ordinary shares directly, a figure that includes ordinary shares subject to outstanding restricted stock units, as noted in the filing's explanation of responses.

The second transaction, coded "A," reflects an acquisition of 6,058 ordinary shares at a price of $0, consistent with an award rather than a market purchase. After this second transaction, Davis's total direct beneficial ownership increased to 23,368 ordinary shares, again inclusive of shares subject to outstanding restricted stock units. The filing does not describe the specific plan or program under which the award was granted.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Sarah Davis and dated November 10, 2026. The filing was submitted by one reporting person. No amendment date was indicated, suggesting this is an original filing.

What Was Disclosed

Amdocs Ltd director Sarah R. Davis disclosed two transactions in ordinary shares on November 9, 2026: a purchase of 822 shares at $42.7341 each and an award of 6,058 shares at $0, bringing her total direct beneficial ownership to 23,368 shares, including restricted stock units.